Trillium Therapeutics Inc. (TRIL) has 9 open-market insider trades by 4 insiders since 2021. The most active filer is Robert Uger, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jan Skvarka | CEOPres | — | 2 | $2.8M | 2021-05-12 |
| Robert Uger | CSO | — | 3 | $225K | 2021-07-07 |
| Penka Petrova | — | — | 3 | $185K | 2021-04-08 |
| James T. Parsons | CFO | — | 1 | $134K | 2021-01-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Uger | Chief Scientific Officer | Sell | $33K | 2021-07-07 |
| Robert Uger | Chief Scientific Officer | Sell | $30K | 2021-06-07 |
| Jan Skvarka | CEO & President | Sell | $2.4M | 2021-05-11 |
| Robert Uger | Chief Scientific Officer | Sell | $34K | 2021-05-07 |
| Penka Petrova | — | Sell | $118K | 2021-04-08 |
| Robert Uger | Chief Scientific Officer | Sell | $39K |
Companies that share insiders with TRIL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-04-07 |
| Robert Uger | Chief Scientific Officer | Sell | $35K | 2021-03-12 |
| Penka Petrova | — | Sell | $118K | 2021-03-10 |
| Robert Uger | Chief Scientific Officer | Sell | $37K | 2021-03-08 |
| Robert Uger | CSO | Sell | $174K | 2021-02-08 |
| Penka Petrova | — | Sell | $142K | 2021-02-08 |
| Jan Skvarka | CEO & President | Sell | $752K | 2021-01-13 |
| Penka Petrova | Chief Development Officer | Sell | $8K | 2021-01-11 |
| Robert Uger | Chief Scientific Officer | Sell | $9K | 2021-01-11 |
| James T. Parsons | CFO | Sell | $269K | 2021-01-08 |